XML 23 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation
3 Months Ended
May 04, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
The stock-based compensation costs that have been charged against income were as follows (in thousands):

13-Weeks Ended
May 4,
2024
April 29,
2023
Stock-based compensation expense by type:
Stock options
$— $220 
Restricted stock units2,320 1,653 
Employee stock purchases
134 106 
Director deferred compensation27 26 
  Total stock-based compensation expense2,481 2,005 
Income tax benefit recognized572 454 
  Stock-based compensation expense, net of income tax$1,909 $1,551 

Expense for restricted stock units is shown net of forfeitures, which were immaterial for the 13-weeks ended May 4, 2024 and April 29, 2023.
We granted the following equity awards:
13-Weeks Ended
May 4,
2024
April 29,
2023
Stock options
— 8,188 
Restricted stock unit awards
59,841 78,515 
Performance-based restricted stock unit awards
33,211 39,567 
Deferred stock units
359 450 

At May 4, 2024, the total compensation cost not yet recognized related to unvested restricted stock unit awards was $10.4 million and the weighted-average period over which such awards are expected to be recognized was 1.3 years. There were no unrecognized compensation costs related to unvested stock options at May 4, 2024.
Details of stock options granted, exercise price per share and the weighted-average grant date fair value were as follows:

13-Weeks Ended
May 4,
2024
April 29,
2023
Total stock options granted— 8,188 
Exercise price$— $58.38 
Fair value of stock options$— $26.87 
Under the Hibbett, Inc. Amended and Restated Non-Employee Director Equity Plan, 12,689 shares of our common stock were subject to awards granted during the 13-weeks ended May 4, 2024 and 10,469 shares of our common stock were awarded during the 13-weeks ended April 29, 2023.
The number of shares purchased, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows:
13-Weeks Ended
May 4,
2024
April 29,
2023
Shares purchased7,170 7,026 
Average price per share$61.22 $50.13 
Weighted-average fair value at grant date$18.90 $17.60